Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.

Autor: Yardley DA; Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville, TN. Electronic address: dyardley@tnonc.com., Reeves J; Florida Cancer Specialists and Research Institute, Fort Myers, FL., Dees EC; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., Osborne C; Baylor Charles A. Sammons Cancer Center, US Oncology Research, Dallas, TX., Paul D; Rocky Mountain Cancer Centers, US Oncology Research, Denver, CO., Ademuyiwa F; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO., Soliman H; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Guthrie T; Baptist Cancer Institute, Jacksonville, FL., Andersen J; Northwest Cancer Specialists, PC, US Oncology Research, Portland, OR., Krekow L; Texas Oncology-Bedford, US Oncology Research, Bedford, TX., Choksi J; Medical Oncologist, Alamance Regional Medical Center, Burlington, NC., Daniel B; Tennessee Oncology, Chattanooga, TN., Danso M; Virginia Oncology Associates, US Oncology Research, Norfolk, VA., Favret A; Virginia Cancer Specialists, PC, US Oncology Research, Fairfax, VA., Oommen S; Texas Oncology-Fort Worth, US Oncology Research, Fort Worth, TX., Brufsky A; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Magee-Women's Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA., Bromund JL; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN., Lin Y; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN., Ibrahim AB; Eli Lilly and Company, Bridgewater, NJ., Richards PD; Oncology and Hematology Associates of Southwest Virginia, US Oncology Research, Salem, VA.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2016 Dec; Vol. 16 (6), pp. 471-479.e1. Date of Electronic Publication: 2016 Jul 29.

Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.

Autor: Dudek AZ; University of Minnesota Comprehensive Cancer Center, Minneapolis, Minnesota 55455, USA. dudek002@umn.edu, Larson T, McCleod MJ, Schneider DJ, Dowell JE, Banerjee TK, Pandya KJ, Bromund JL, Chen R, Monberg MJ, Obasaju CK

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2008 Apr; Vol. 3 (4), pp. 394-9.